JP2024519814A5 - - Google Patents
Info
- Publication number
- JP2024519814A5 JP2024519814A5 JP2023571295A JP2023571295A JP2024519814A5 JP 2024519814 A5 JP2024519814 A5 JP 2024519814A5 JP 2023571295 A JP2023571295 A JP 2023571295A JP 2023571295 A JP2023571295 A JP 2023571295A JP 2024519814 A5 JP2024519814 A5 JP 2024519814A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- salt
- compound
- target
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189522P | 2021-05-17 | 2021-05-17 | |
| US63/189,522 | 2021-05-17 | ||
| PCT/US2022/029535 WO2022245759A2 (en) | 2021-05-17 | 2022-05-17 | Agents for directed conjugation techniques and conjugated products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519814A JP2024519814A (ja) | 2024-05-21 |
| JP2024519814A5 true JP2024519814A5 (cg-RX-API-DMAC10.html) | 2025-05-23 |
Family
ID=84140970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571295A Pending JP2024519814A (ja) | 2021-05-17 | 2022-05-17 | 指向性コンジュゲーション技術のための薬剤及びコンジュゲート生成物 |
Country Status (11)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12023553152A1 (en) * | 2021-05-17 | 2024-03-11 | Biohaven Therapeutics Ltd | Compositions including conjugated therapy enhancers |
| WO2026150353A2 (en) | 2025-01-11 | 2026-07-16 | Biohaven Therapeutics Ltd. | Antibody-drug conjugates for delivering cytotoxic agents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US20140079636A1 (en) * | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| AU2014372833B2 (en) * | 2013-12-23 | 2019-08-22 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) |
| WO2017042944A1 (ja) * | 2015-09-10 | 2017-03-16 | 国立大学法人山梨大学 | フィラデルフィア染色体陽性(Ph+)急性リンパ性白血病(ALL)の治療薬又は治療方法 |
| CA3061467A1 (en) * | 2017-04-28 | 2019-10-24 | Ajinomoto Co., Inc. | Compound having affinity substance to soluble protein, cleavable portionand reactive group, or salt thereof |
| SG11202000628XA (en) * | 2017-07-26 | 2020-02-27 | Kleo Pharmaceuticals Inc | Universal abt compounds and uses thereof |
| JP7404230B2 (ja) * | 2017-09-18 | 2023-12-25 | トラスティーズ オブ ボストン ユニバーシティ | ネトーシスおよび好中球活性化を処置するための方法 |
| WO2019241609A1 (en) * | 2018-06-15 | 2019-12-19 | Trustees Of Boston University | Polypeptide compositions and methods for site-specific targeting of therapeutic agents |
| CA3143513A1 (en) * | 2019-07-03 | 2021-01-07 | Kleo Pharmaceuticals, Inc. | Cd38-binding agents and uses thereof |
-
2022
- 2022-05-17 IL IL307799A patent/IL307799A/en unknown
- 2022-05-17 CA CA3219517A patent/CA3219517A1/en active Pending
- 2022-05-17 US US18/555,857 patent/US20240252674A1/en active Pending
- 2022-05-17 PH PH1/2023/553154A patent/PH12023553154A1/en unknown
- 2022-05-17 AU AU2022275832A patent/AU2022275832A1/en active Pending
- 2022-05-17 CN CN202280034207.3A patent/CN117750979A/zh active Pending
- 2022-05-17 JP JP2023571295A patent/JP2024519814A/ja active Pending
- 2022-05-17 EP EP22805274.2A patent/EP4340891A4/en active Pending
- 2022-05-17 KR KR1020237039500A patent/KR20240012380A/ko active Pending
- 2022-05-17 WO PCT/US2022/029535 patent/WO2022245759A2/en not_active Ceased
- 2022-05-17 MX MX2023013272A patent/MX2023013272A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6942147B2 (ja) | Mt1−mmpに対して特異的な二環式ペプチド−毒素コンジュゲート | |
| EP2651964B1 (en) | Cross-linked peptides and proteins, methods of making same, and uses thereof | |
| JP2022517698A (ja) | インテグリンαvβ3に特異的な二環式ペプチドリガンド | |
| JP2022514687A (ja) | Pd-l1に特異的な二環式ペプチドリガンド | |
| CN110114075A (zh) | 含有二硫化物的细胞穿透肽及其制备和使用方法 | |
| JP2021507909A (ja) | EphA2に特異的な二環ペプチドリガンド | |
| JP2020514403A (ja) | Mt1−mmpに結合するためのペプチドリガンド | |
| EP3432935B1 (en) | Site-specific bio-conjugation methods and compositions useful for nanopore systems | |
| AU2022234694B2 (en) | Compound or salt thereof, and antibody obtained using same | |
| JP7794789B2 (ja) | タンパク質精製のための超分子フィラメント集合体 | |
| JP2024521092A5 (cg-RX-API-DMAC10.html) | ||
| AU2022208654B2 (en) | Compound or salt thereof, and antibody produced using same | |
| US8829157B2 (en) | Process for the synthesis of cyclic heptapeptide | |
| CN105254655B (zh) | 一种基于bodipy的荧光氨基酸及其合成方法与应用 | |
| JP6977058B2 (ja) | ピクテ・スペングラー反応を介して得られたタグ付けヌクレオシドを用いたシーケンシング反応のための方法 | |
| JP2024519814A (ja) | 指向性コンジュゲーション技術のための薬剤及びコンジュゲート生成物 | |
| US12351619B2 (en) | Serum albumin-binding fibronectin type III domains and uses thereof | |
| JPH06239898A (ja) | 免疫抱合体の調製法 | |
| WO2020195302A1 (ja) | 細胞膜透過性環状ペプチド作製用リンカー分子、及びその利用 | |
| WO2022116141A1 (zh) | 抗体药物偶联物、其中间体、制备方法及应用 | |
| JPWO2016060096A1 (ja) | ホスホリルコリン基含有化合物およびホスホリルコリン複合体 | |
| JP2023501720A5 (cg-RX-API-DMAC10.html) | ||
| CN107935895B (zh) | 化合物及其制备方法和应用 | |
| Tessier et al. | Chapter IV. Ethynylation of Cysteine Residues: From Peptides to Proteins in Vitro and in Living Cells | |
| CN116854785A (zh) | 位点特异性修饰和标记的抗病毒肽氰病毒素n |